
A framework that can evaluate the risk of resistance for antimalarial compounds has been developed by Medicines for Malaria Venture, a new report published in the Malaria Journal reveals. Resistance defines the longevity of every anti-infective drug, so it is important when developing new medicines for malaria, to check how easily promising antimalarial compounds will select for resistance. Once this is known, it facilitates the prioritization of not only the most ...

via Medindia Health News
More READ

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2012/08/framework-for-evaluation-of-risk-of.html
No comments:
Post a Comment